John Libbey Eurotext

VEGF Actu

Les anti-angiogéniques bientôt en traitement adjuvant ? Volume 12, issue 1, Mars 2017

Figures

Author
1 Université de Bordeaux, Inserm U1218, France
  • Key words: VEGF, angiopoïétines, associations thérapeutiques, chimiothérapie adjuvante
  • DOI : 10.1684/veg.2017.0073
  • Page(s) : 2
  • Published in: 2017

Wu et al. Efficacy of cotargeting angiopoietin-2 and the VEGF pathway in the adjuvant postsurgical setting for early breast, colorectal, and renal cancers. Cancer Research 2016; 76: 6988-7000.